A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
| Status: | Completed |
|---|---|
| Conditions: | Lung Cancer, Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | March 2005 |
| End Date: | April 2006 |
The purpose of this study is to find a safe and effective dose of Erbitux and Iressa for
subject with non small cell lung cancer.
subject with non small cell lung cancer.
Inclusion Criteria:
- Subjects with advanced or metastatic non small cell lung cancer.
- Subjects should have had at least one prior chemotherapy with a platinum based
therapy.
Exclusion Criteria:
- Subjects are excluded from this study if they do not have non small cell lung cancer
that is advanced or metastatic or have not had at least one prior platinum based
chemotherapy.
We found this trial at
1
site
Click here to add this to my saved trials
